XOMA Royalty Corporation (XOMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, XOMA Royalty Corporation (XOMA) has a cash flow conversion efficiency ratio of 0.054x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($6.04 Million) by net assets ($112.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is XOMA Royalty Corporation's balance sheet to measure how much of total assets are equity-financed.
XOMA Royalty Corporation - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how XOMA Royalty Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check XOMA Royalty Corporation (XOMA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
XOMA Royalty Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of XOMA Royalty Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tropicana Corporation Bhd
KLSE:5401
|
-0.058x |
|
Ruitai Materials Technology Co Ltd
SHE:002066
|
-0.153x |
|
Beazer Homes USA Inc
NYSE:BZH
|
0.054x |
|
JDM Jingda Mach(Ningbo)Co Ltd
SHG:603088
|
0.077x |
|
Ottogi
KO:007310
|
0.019x |
|
Turkiye Sinai Kalkinma Bankasi AS
IS:TSKB
|
0.071x |
|
Baskent Dogalgaz Dagitim Gayrimenkul Yatirim Ortakligi AS
IS:BASGZ
|
0.041x |
|
COMSTOCK HLDG-A
F:CHO
|
N/A |
Annual Cash Flow Conversion Efficiency for XOMA Royalty Corporation (1989–2025)
The table below shows the annual cash flow conversion efficiency of XOMA Royalty Corporation from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see XOMA Royalty Corporation (XOMA) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $103.96 Million | $2.87 Million | 0.028x | +116.46% |
| 2024-12-31 | $81.92 Million | $-13.75 Million | -0.168x | +18.00% |
| 2023-12-31 | $88.72 Million | $-18.16 Million | -0.205x | -97.07% |
| 2022-12-31 | $124.01 Million | $-12.88 Million | -0.104x | -164.97% |
| 2021-12-31 | $141.88 Million | $22.68 Million | 0.160x | +36.88% |
| 2020-12-31 | $86.42 Million | $10.09 Million | 0.117x | +1902.32% |
| 2019-12-31 | $43.99 Million | $-285.00K | -0.006x | +99.04% |
| 2018-12-31 | $18.79 Million | $-12.64 Million | -0.673x | -244.99% |
| 2017-12-31 | $5.79 Million | $2.69 Million | 0.464x | -34.95% |
| 2016-12-31 | $-47.21 Million | $-33.69 Million | 0.714x | -94.67% |
| 2015-12-31 | $-2.31 Million | $-30.89 Million | 13.379x | +152.96% |
| 2014-12-31 | $3.10 Million | $-78.28 Million | -25.260x | -319.35% |
| 2013-12-31 | $-3.99 Million | $-45.91 Million | 11.516x | +706.45% |
| 2012-12-31 | $21.47 Million | $-40.77 Million | -1.899x | +1.92% |
| 2011-12-31 | $15.01 Million | $-29.06 Million | -1.936x | +13.06% |
| 2010-12-31 | $23.59 Million | $-52.54 Million | -2.227x | -624.95% |
| 2009-12-31 | $17.53 Million | $7.43 Million | 0.424x | -59.60% |
| 2008-12-31 | $-31.40 Million | $-32.98 Million | 1.050x | -92.65% |
| 2007-12-31 | $318.00K | $4.54 Million | 14.286x | +1539.15% |
| 2006-12-31 | $-38.17 Million | $-33.27 Million | 0.872x | -59.23% |
| 2005-12-31 | $-20.67 Million | $-44.19 Million | 2.138x | +17.36% |
| 2004-12-31 | $-24.61 Million | $-44.83 Million | 1.821x | +284.74% |
| 2003-12-31 | $48.21 Million | $-47.54 Million | -0.986x | -132.16% |
| 2002-12-31 | $-11.37 Million | $-34.84 Million | 3.066x | +286.21% |
| 2001-12-31 | $13.62 Million | $-22.42 Million | -1.646x | -162.96% |
| 2000-12-31 | $-8.59 Million | $-22.46 Million | 2.615x | +2.53% |
| 1999-12-31 | $-16.90 Million | $-43.10 Million | 2.550x | +101.35% |
| 1998-12-31 | $200.00K | $-37.70 Million | -188.500x | -48910.00% |
| 1997-12-31 | $31.20 Million | $-12.00 Million | -0.385x | +40.42% |
| 1996-12-31 | $34.70 Million | $-22.40 Million | -0.646x | +40.14% |
| 1995-12-31 | $26.80 Million | $-28.90 Million | -1.078x | -64.59% |
| 1994-12-31 | $43.50 Million | $-28.50 Million | -0.655x | -77.74% |
| 1993-12-31 | $78.40 Million | $-28.90 Million | -0.369x | +4.61% |
| 1992-12-31 | $88.50 Million | $-34.20 Million | -0.386x | -88.32% |
| 1991-12-31 | $134.50 Million | $-27.60 Million | -0.205x | +76.03% |
| 1990-12-31 | $26.40 Million | $-22.60 Million | -0.856x | -26.77% |
| 1989-12-31 | $27.10 Million | $-18.30 Million | -0.675x | -- |
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with co… Read more